Business Description
Founded in 2001 and based in Chuncheon-si, South Korea, Hugel Inc. is a biopharmaceutical company that produces and sells a range of medical and cosmetic products across global markets. Its core offering is a botulinum toxin injection, sold under multiple brand names, which is used to treat conditions such as eyelid spasms, limb stiffness in stroke patients, and foot deformity in children with cerebral palsy, as well as to reduce facial wrinkles in adults. The company also markets hyaluronic acid dermal fillers, a cosmetics line under the Wellage brand, and medical devices under the BlueRose brand.
